Ebola deaths in Africa, 1,013, Europe 1, U.S. 0
Spanish priest becomes first European to die in Ebola outbreak
http://www.trbimg.com/img-53ea192a/t...40812/550/16x9
Aid workers and doctors transfer Miguel Pajares, a Spanish priest who was infected with the Ebola virus while working in Liberia. (Spanish Defense Ministry / Associated Press)
By LAUREN FRAYER
Europe records its first Ebola death
Spanish priest is first European to die from current outbreak of Ebola virus
Elderly Spanish cleric who died from Ebola was to have been treated with experimental drug
A 75-year-old Spanish priest suffering from the Ebola virus died Tuesday in an isolation ward in Madrid -- the first European death from the outbreak that has killed more than 1,000 people in West Africa and the first known death on European soil.
Miguel Pajares died around 9:30 a.m. Tuesday at Madrid's Carlos III Hospital, Spanish officials announced.
We had hoped that he would be able to overcome the disease. But it was as God wished.- Carmen Romo, sister-in-law of Spanish priest who died from Ebola
A Roman Catholic missionary, Pajares was airlifted Aug. 7 from Liberia, where he is believed to have contracted the deadly virus at a hospital where he worked. Thousands of Spaniards had joined a social media campaign urging their government to rescue and repatriate him. He was the first Ebola patient evacuated to Europe amid the current, fast-spreading outbreak in Africa, which is already the worst in history.
"We had hoped that he would be able to overcome the disease," the priest's sister-in-law, Carmen Romo, told a Spanish radio station. "But it was as God wished."
lRelatedhttp://www.trbimg.com/img-53d2ee96/t...140725/150/1x1
AFRICA Ebola emergency in West Africa: What you need to know SEE ALL RELATED
Spanish health officials sparked controversy over the weekend when they obtained a batch of a rare experimental U.S.-made drug to treat Pajares. Zmapp, made by San Diego-based Mapp Biopharmaceutical Inc., is the same drug being used to treat two American Ebola patients in Atlanta, who were also evacuated from West Africa.
In extremely short supply, the drug is unproven for use on humans, but has shown promise in animal tests. The company hadn't planned to begin human testing until next year. But the drug has nevertheless been given to a small number of Ebola patients, all of them Westerners working for foreign aid agencies, rather than Africans, who comprise the vast majority of Ebola's victims.
http://www.trbimg.com/img-53e4933d/t...40808/550/16x9
CAPTIONEbola checkChoe Jae-koo / Associated Press
A quarantine officer checks the body temperature of a passenger as a precaution against the Ebola virus at the Incheon International Airport in South Korea. South Korea has stepped up monitoring of citizens returning from West Africa.
After convening an ethics panel to discuss the distribution of such experimental drugs, the World Health Organization on Tuesday endorsed their use, saying "it is ethical to offer unproven interventions with as-yet unknown efficacy and adverse effects, as potential treatment or prevention," according to a statement posted on its website.
The government of Liberia also announced Tuesday that it was acquiring doses of Zmapp to treat two Liberian doctors. The experimental serum should arrive in Liberia within 48 hours, the Liberian government said on its website.
Citing health privacy rules, hospital officials would not disclose whether Pajares had already received his Zmapp dose, or whether he died before he could be treated with it.
Two of the priest's coworkers in Liberia have also died of the virus. All belonged to the Order of San Juan de Dios, a Catholic humanitarian group that runs hospitals around the world. Pajares was repatriated to Spain with a nun, Juliana Bohi, 65, who is a dual citizen of Equatorial Guinea and Spain. She is still being kept in isolation at the same Madrid hospital, but has so far tested negative for Ebola.
The WHO says at least 1,013 people have died from Ebola in Guinea, Liberia, Nigeria and Sierra Leone.
http://www.latimes.com/world/europe/...812-story.html